Pharmabiz

Union government appoints Deepika Padukone, founder LLL Foundation as ‘Mental Health Ambassador’

Union government’s ministry of health and family welfare has now partnered with Deepika Padukone, actor and founder of The Live Love Laugh (LLL) Foundation, to be appointed as the first-ever ‘Mental ...
Pharmabiz

PharmaTech Expo & LabTech Expo 2025 to take place at Bengaluru from Dec 19 to 21

PharmaTech Expo & LabTech Expo 2025 to take place at Bengaluru from Dec 19 to 21: Our Bureau, Mumbai Monday, October 13, 2025, 09:00 Hrs [IST] The 21st edition of PharmaTech Expo ...
Pharmabiz

Govt’s move to open consultation on cost of regulatory compliance for new drug approval to impact affordability

Govt’s move to open consultation on cost of regulatory compliance for new drug approval to impact affordability: Shardul Nautiyal, Mumbai Monday, October 13, 2025, 08:00 Hrs [IS ...
Pharmabiz

DoP rolls out sensitisation programmes to guide pharma, medtech industry on amended PRIP scheme

DoP rolls out sensitisation programmes to guide pharma, medtech industry on amended PRIP scheme: Shardul Nautiyal, Mumbai Monday, October 13, 2025, 08:00 Hrs [IST] The Department ...
Pharmabiz

CDSCO announces 100-day campaign by stakeholders to publicise GST rationalisation

CDSCO announces 100-day campaign by stakeholders to publicise GST rationalisation: Gireesh Babu, New Delhi Monday, October 13, 2025, 08:00 Hrs [IST] The Central Drugs Standard Con ...
Pharmabiz

PRIP scheme fuels India's pharma-biotech revolution through innovation-driven policies

PRIP scheme fuels India's pharma-biotech revolution through innovation-driven policies: Nandita Vijayasimha, Bengaluru Monday, October 13, 2025, 08:00 Hrs [IST] India’s Promotio ...
Pharmabiz

EY-Parthenon and FICCI unveils report on 'True Accountable Care: Maximizing Healthcare Delivery Impact, Efficiently’

EY-Parthenon and FICCI releases a report titled 'True Accountable Care: Maximizing Healthcare Delivery Impact, Efficiently’ ...
Pharmabiz

ARS Pharmaceuticals receives favourable decision from EPO on nasal spray ‘neffy’ for emergency treatment of allergic reactions

ARS Pharmaceuticals receives favourable decision from EPO on nasal spray ‘neffy’ for emergency treatment of allergic reactions: San Diego Saturday, October 11, 2025, 13:00 Hrs ...
Pharmabiz

Lexeo Therapeutics reports progress in US FDA discussions for accelerated approval pathway for LX2006 in Friedreich ataxia cardiomyopathy

Lexeo Therapeutics reports progress in US FDA discussions for accelerated approval pathway for LX2006 in Friedreich ataxia cardiomyopathy: New York Saturday, October 11, 2025, 16: ...
Pharmabiz

Chugai Pharma concludes license agreement with Roche for CT-388, a long-acting GLP-1/GIP receptor agonist

Chugai Pharma concludes license agreement with Roche for CT-388, a long-acting GLP-1/GIP receptor agonist: Tokyo Saturday, October 11, 2025, 11:00 Hrs [IST] Chugai Pharmaceutical ...
Pharmabiz

Werewolf Therapeutics gets US FDA fast track designation for its investigational therapy WTX-124 for treatment of cancer

Werewolf Therapeutics gets US FDA fast track designation for its investigational therapy WTX-124 for treatment of cancer: Watertown, Massachusetts Saturday, October 11, 2025, 14:0 ...
Pharmabiz

Nasus Pharma collaborates with Aptar to support development and commercialization of NS002

Nasus Pharma collaborates with Aptar to support development and commercialization of NS002: Tel Aviv Saturday, October 11, 2025, 12:00 Hrs [IST] Nasus Pharma Ltd, a clinical-stage ...